You are here

BMJ

Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic

Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic

Medical Xpress

Flag link:

BMJ finds 96% of oncology drug developers inadequately include minority groups

BMJ finds 96% of oncology drug developers inadequately include minority groups

Clinical Trials Arena

drug development

Flag link: